Status
Conditions
Treatments
About
This clinical study evaluates the safety and efficacy of the treatment with the CoolLoop® cryoablation System (sclerotherapy of muscle tissue of the heart by freezing) in patients with atrial fibrillation (permanent atrial fibrillation excepted) over a follow-up period of 36 months.
A further aim of this study is to evaluate the average duration of procedure and fluoroscopy times.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
540 participants in 1 patient group
Loading...
Central trial contact
Andreas Kaiser, PhD; afreeze GmbH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal